| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3866484 | The Journal of Urology | 2010 | 7 Pages |
Abstract
Angiogenesis related molecular markers are commonly altered in urothelial carcinoma of the bladder, making them a target for therapy. Down-regulation of thrombospondin 1 and up-regulation of basic fibroblast growth factor are independent predictors of clinical outcomes of patients with urothelial carcinoma of the bladder.
Keywords
MVDTSP-1UCBbFGFImmunohistochemistrySurvivalMicrovessel densitythrombospondin 1Urinary bladder neoplasmsRadical cystectomyvascular endothelial growth factorsRecurrenceVascular endothelial growth factorVascular Endothelial Growth Factor (VEGF)basic fibroblast growth factorUrothelial carcinoma of the bladderLymph node
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Shahrokh F. Shariat, Ramy F. Youssef, Amit Gupta, Daher C. Chade, Pierre I. Karakiewicz, Hendrik Isbarn, Claudio Jeldres, Arthur I. Sagalowsky, Raheela Ashfaq, Yair Lotan,